Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALCINA: Circulating Tumor Markers Analysis
NCT02866149Completed
- Sponsor
- Institut Curie
- Start
- Jul 2015
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Open-label trial (16 cohorts), sponsored by Institut Curie. Primary endpoint: Feasibility of the analysis of different blood-borne tumor biomarkers at 18 months. Started Jul 2015; status: completed.
Beyond the preview
Go deeper on NCT02866149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866149.